Medicine reading guide
Imatinib (Gleevec)
Gleevec for newly diagnosed chronic-phase Philadelphia-chromosome-positive CML in adults. Educational draft. Independent clinical review pending. Not personal medical advice.
How it works
Your bone marrow, the soft tissue inside bones, makes blood cells. In the type of leukemia covered here, a DNA change makes a protein that keeps sending a signal for cells to grow. Imatinib blocks that protein, turning down the signal. Some leukemia cells stop growing and some die, helping bring their number down. Feeling well does not show whether leukemia remains, so the cancer team uses tests to follow treatment.
Audience explanation sources
Editorial source review completed November 11, 2026. Independent clinical review pending. Audience versions explain the same scoped medicine; they are not separate treatment plans.
Educational draft. Independent clinical review pending.
Written explanation
Adults using oral Gleevec tablets for newly diagnosed Philadelphia-chromosome-positive chronic myeloid leukemia in chronic phase. Excludes later phases, other cancers, children and liquid products.
Written claims and linked sources rechecked November 11, 2026. Independent clinical review pending.
Abnormal signal: the Philadelphia chromosome produces BCR-ABL, a persistently active tyrosine kinase in this leukemia.
Signal inhibited: imatinib blocks BCR-ABL kinase activity. Laboratory studies show reduced growth and increased death of BCR-ABL-positive cells.
Which use does this guide cover?
Newly diagnosed Ph+ chronic myeloid leukemia in chronic phase.
How does it work?
It blocks the abnormal BCR-ABL kinase that drives these leukemia cells.
How should tablets be taken with food?
Take with a meal and a large glass of water, following your prescription.
What if I cannot swallow tablets?
Ask your pharmacist about the labeled dispersion method; do not improvise crushing or mixing.
What side effects might occur?
Nausea, diarrhea, muscle cramps, skin changes or swelling.
Which symptoms need immediate help?
Contact your team immediately for rapid weight gain, breathlessness, fever, unusual bleeding or yellow skin/eyes.
Why are blood counts checked?
Imatinib can lower red cells, infection-fighting cells and platelets.
Why monitor liver function?
Serious liver injury can occur; testing is needed before and during treatment.
What medicines or foods need checking?
Review all medicines and supplements, including St. John's wort. Avoid grapefruit and grapefruit juice.
What about pregnancy or breastfeeding?
Imatinib can harm an unborn baby. Discuss pregnancy prevention with your cancer team; the Gleevec label advises effective contraception during treatment and for 14 days after stopping for patients who could become pregnant. Do not breastfeed during treatment or for one month after the last dose.